VivaBioCell

About:

VivaBioCell develops products based on cell culture and tissue engineering for the diagnosis of autoimmune diseases.

Website: http://www.vivabiocell.it

Top Investors: Banca Popolare di Cividale, Friulia SGR, Generali Horizon

Description:

VivaBioCell is a company developing innovative products, coming from proprietary technologies in cell culture and tissue engineering, to fit unmet medical needs and aimed to early diagnosis of autoimmune diseases (scleroderma, graft versus host disease) and treatment of oro-dental and maxillo-facial defects. VivaBioCell intends to perform these activities by means of owned, already developed technologies, by setting-up new innovative technologies and by identifying new opportunities through the collaborations with recognised academic research centres, in particular in Italy.